Surgical Science Valuation
| SUS Stock | SEK 174.40 1.40 0.81% |
At this time, the company appears to be undervalued. Surgical Science Sweden has a current Real Value of kr188.92 per share. The regular price of the company is kr174.4. Our model measures the value of Surgical Science Sweden from inspecting the company fundamentals such as Operating Margin of 0.19 %, return on equity of 0.0357, and Shares Outstanding of 50.8 M as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Surgical Science's price fluctuation is very steady at this time. Calculation of the real value of Surgical Science Sweden is based on 3 months time horizon. Increasing Surgical Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Surgical Science's intrinsic value may or may not be the same as its current market price of 174.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 174.4 | Real 188.92 | Hype 174.4 | Naive 181.04 |
The intrinsic value of Surgical Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Surgical Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Surgical Science Sweden helps investors to forecast how Surgical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgical Science more accurately as focusing exclusively on Surgical Science's fundamentals will not take into account other important factors: Surgical Science Total Value Analysis
Surgical Science Sweden is at this time projected to have takeover price of 7.68 B with market capitalization of 8.1 B, debt of 160.68 M, and cash on hands of 316.68 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Surgical Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.68 B | 8.1 B | 160.68 M | 316.68 M |
Surgical Science Investor Information
About 33.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.83. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgical Science Sweden had not issued any dividends in recent years. The entity had 5:1 split on the 25th of May 2020. Based on the measurements of operating efficiency obtained from Surgical Science's historical financial statements, Surgical Science Sweden is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Surgical Science Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Surgical Science has an asset utilization ratio of 9.22 percent. This implies that the Company is making kr0.0922 for each dollar of assets. An increasing asset utilization means that Surgical Science Sweden is more efficient with each dollar of assets it utilizes for everyday operations.Surgical Science Ownership Allocation
Surgical Science Sweden shows a total of 50.8 Million outstanding shares. Over half of Surgical Science's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Surgical Science Sweden. Please watch out for any change in the institutional holdings of Surgical Science as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Surgical Science Profitability Analysis
The company reported the revenue of 366.78 M. Net Income was 86.25 M with profit before overhead, payroll, taxes, and interest of 265.94 M.About Surgical Science Valuation
The stock valuation mechanism determines Surgical Science's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Surgical Science Sweden based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Surgical Science. We calculate exposure to Surgical Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgical Science's related companies.Surgical Science Sweden AB develops and markets virtual reality simulators for evidence based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Surgical Science's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Surgical Science's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Surgical Science's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Surgical Science's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Surgical Science's revenue streams: Identify Surgical Science's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Surgical Science's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Surgical Science's growth potential: Evaluate Surgical Science's management, business model, and growth potential.
- Determine Surgical Science's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Surgical Science's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.